Relmada begins pharmacokinetic trial for new oral formulations of buprenorphine
The trial is designed to evaluate the safety, tolerability, and pharmacokinetics of BuTab in healthy subjects. Main objective of the trial is to assess if buprenorphine can be
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.